Hemoptysis News and Research

RSS
FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare receives FDA approval for Adempas tablets

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

Synta announces results from ganetespib Phase 2b trial on NSCLC

Synta announces results from ganetespib Phase 2b trial on NSCLC

LVRC safe and effective choice for patients with severe heterogeneous emphysema

LVRC safe and effective choice for patients with severe heterogeneous emphysema

Combination treatment shows promise against NSCLC patients ineligible for bevacizumab

Combination treatment shows promise against NSCLC patients ineligible for bevacizumab

Final results from Vertex KALYDECO second of two Phase 3 studies on CF

Final results from Vertex KALYDECO second of two Phase 3 studies on CF

Diagnostic delay in women with tuberous sclerosis complex increases mortality risk

Diagnostic delay in women with tuberous sclerosis complex increases mortality risk

Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function

Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present oncology portfolio results at ESMO Congress

Amgen to present oncology portfolio results at ESMO Congress

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Bevacizumab drug shows promise to slow tumor growth in lung cancer patients

Bevacizumab drug shows promise to slow tumor growth in lung cancer patients

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer